arrow
B

Bettzy Stephen

ut md anderson cancer center
H指数:20
被引数:1,845

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies

一项avelumab联合ivuxolimab、utomilumab和放射治疗的I/II期临床试验,用于治疗晚期胃肠道恶性肿瘤患者

2025-03-010
PRE
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study (vol 40, pg 290, 2022)
2025-02-200
OAAI
A phase I study of temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer

一项关于temsirolimus联合metformin治疗晚期或复发性子宫内膜癌的I期研究

2025-02-011
PRE
Autoantibody profiling for predictive biomarkers for immune-related adverse events and clinical benefit in rare tumors treated with anti-PD-1 therapy
2024-03-220
PRE
Phase 1/2 trial of avelumab combined with utomilumab (4-1BB agonist), PF-04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies

avelumab联合utomilumab (4-1BB激动剂),PF-04518600 (OX40激动剂) 或放疗在晚期妇科恶性肿瘤患者中的1/2期试验

CANCER
IF5.1
2023-10-216
PRE
Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial

在II期临床试验中接受pembrolizumab治疗的罕见癌症患者的患者报告症状负担

2022-08-232
OAAI
Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study

检查点抑制剂在血管肉瘤中的临床活性: 一项回顾性队列研究

CANCER
IF5.1
2022-07-0615
PRE
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study (Sep, 10.1007/s10637-021-01188-1, 2021)
2021-11-030
OAAI
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study

Selinexor联合卡铂和紫杉醇治疗晚期实体瘤: 单中心,多臂Ib期研究的结果

2021-09-257
OAAI